HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Halle C F Moore Selected Research

Gastrointestinal Diseases (Functional Gastrointestinal Disorders)

6/2022Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Halle C F Moore Research Topics

Disease

27Breast Neoplasms (Breast Cancer)
06/2022 - 11/2002
11Neoplasms (Cancer)
06/2022 - 01/2006
3Disease Progression
01/2022 - 01/2021
3Fatigue
08/2020 - 01/2007
3Peripheral Nervous System Diseases (PNS Diseases)
11/2018 - 11/2017
2Cognitive Dysfunction
09/2014 - 08/2014
1Diarrhea
06/2022
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
06/2022
1Pneumonia (Pneumonitis)
01/2022
1Circulating Neoplastic Cells
01/2022
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022
1Chronic Pain
08/2020
1Chronic Disease (Chronic Diseases)
01/2019
1Body Weight (Weight, Body)
01/2019
1Premature Menopause
01/2019
1Overweight
12/2017
1Hypesthesia (Numbness)
11/2017
1Obesity
11/2017
1Chemotherapy-Related Cognitive Impairment
09/2014
1Mental Fatigue
08/2014
1Fanconi Anemia (Fanconi's Anemia)
12/2011
1Weight Gain
01/2007

Drug/Important Bio-Agent (IBA)

9Hormones (Hormone)IBA
01/2022 - 01/2006
5Paclitaxel (Taxol)FDA LinkGeneric
10/2020 - 12/2011
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2020 - 12/2011
4taxaneIBA
11/2018 - 12/2011
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 12/2011
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2018 - 01/2015
2ErbB Receptors (EGF Receptor)IBA
06/2022 - 01/2021
2Fulvestrant (Faslodex)FDA Link
01/2022 - 07/2019
2human ERBB2 proteinIBA
01/2022 - 01/2015
2EverolimusFDA Link
01/2022 - 01/2022
2Aromatase InhibitorsIBA
01/2021 - 05/2009
2Letrozole (Femara)FDA LinkGeneric
07/2019 - 05/2009
2Goserelin (Zoladex)FDA Link
01/2019 - 01/2015
1Loperamide (Imodium)FDA LinkGeneric
06/2022
1AntidiarrhealsIBA
06/2022
1Colestipol (Colestid)FDA LinkGeneric
06/2022
1neratinibIBA
06/2022
1Anastrozole (Arimidex)FDA LinkGeneric
01/2022
1trastuzumab deruxtecanIBA
01/2022
1exemestane (Aromasin)FDA Link
01/2022
1Circulating Tumor DNAIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2021
1AntioxidantsIBA
10/2020
1Estrogens (Estrogen)FDA Link
08/2020
1palbociclibIBA
07/2019
1Progesterone Receptors (Progesterone Receptor)IBA
01/2019
1Dietary Fats (Dietary Fat)IBA
01/2019
1Estrogen ReceptorsIBA
01/2019
1Docetaxel (Taxotere)FDA Link
11/2017
1AnthracyclinesIBA
01/2015
1Taxoids (Taxanes)IBA
12/2011
1Zoledronic Acid (Zometa)FDA Link
05/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2008

Therapy/Procedure

15Drug Therapy (Chemotherapy)
01/2022 - 01/2007
12Therapeutics
06/2022 - 01/2006
5Adjuvant Chemotherapy
01/2018 - 01/2007
2Time-to-Treatment
01/2021 - 10/2020
2Mastectomy (Mammectomy)
11/2017 - 05/2007
1Aftercare (After-Treatment)
01/2021
1Shared Medical Appointments
01/2019
1Anesthesia
11/2017
1Cognitive Training
09/2014
1Segmental Mastectomy (Lumpectomy)
05/2007
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
11/2002